Inspiration Biopharmaceuticals, Ipsen deal

Ipsen said it would not be required to pay $12.5 million for equity in Inspiration under terms of an August restructuring of a 2010 hemophilia deal. As a part of the restructuring, Ipsen would have been required to acquire the equity if Inspiration raised third-party financing by Sept. 30. Ipsen also lost an option in August to acquire Inspiration but agreed to make an equity investment of up to $20 million. Inspiration and Ipsen declined to provide details (see BioCentury, Aug. 27). ...